Upcoming Issue Highlights
Home Subscribe Advertise Sourcebook Free Product Info Home

Protein Found to be Associated with Menopausal Bone Loss

Bone and Joint Health Bone and Joint Health

It is known that women who have reached menopause are at a greater risk of developing brittle bones, which can lead to bone fractures and long-term impairment of mobility. Studies have shown a link between reduced bone density and low estrogen levels due to menopause, but the basis for this link is unclear.

Researchers at Tokyo Medical and Dental University (TMDU, Japan) describe a new molecular link between estrogen and bone aging, which may eventually lead to new strategies to preserve bone health in postmenopausal women.

Bone is a complex tissue, consisting of a matrix of proteins and minerals that give it the flexibility and strength to support body movement. Bone also contains several types of specialized cells, including osteocytes, that help to maintain this matrix. Over a person’s lifetime, many factors can affect how healthy bone structure is maintained. One of these factors is the female sex hormone, estrogen.

“Over the last few decades, we’ve learned that estrogen plays an important role in maintaining a functional bone matrix,” explained co-authors Tomoki Nakashima and Hiroshi Takayanagi. “Exactly how estrogen does this, though, is not fully understood. Our laboratory recently discovered that bone matrix is maintained by a protein called Sema3A, which is secreted by osteocytes. This led us to suspect that there might be a mechanistic relationship between estrogen and Sema3A.”

Sema3A does indeed appear to be linked to estrogen: the researchers found that blood serum levels of the protein decrease in premenopausal women as they get older—and drop even further once women reach menopause. But how, at the biological level, are estrogen and Sema3A related? And what is Sema3A doing in bone tissue?

“When we genetically removed Sema3A from the osteoblast lineage cells (including osteocytes) of mice, we found that intravenous estrogen no longer prevented bones from deteriorating after an ovariectomy,” lead author Mikihito Hayashi describes. “In addition, we found that Sema3A sets off a chain of signaling events that promote the survival of osteocytes in these mice. This suggests that Sema3A serves as a key mechanistic link between estrogen and bone maintenance. We believe that, as women lose estrogen with age and Sema3A levels drop off, osteocytes begin to die and bone loses the ability to maintain its supportive structure.”

The researchers hope that the discovery of Sema3A as a major player in bone health and the signaling molecules it controls in bone may offer new therapeutic approaches to supporting bone health.


Hayashi M, et al. “Autoregulation of Osteocyte Sema3A Orchestrates Estrogen Action and Counteracts Bone Aging.” Cell Metabolism, 2019; 29 (3): 627 DOI: 10.1016/j.cmet.2018.12.021